Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Aim Immunotech Inc (AIM)

Aim Immunotech Inc (AIM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aim Immunotech Inc 2117 SW HIGHWAY 484 OCALA FL 34473 USA

P: 352-448-7797

Description:

AIM ImmunoTech Inc. is an immuno-pharma company. It is focused on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency diseases. The company's flagship products include Ampligen(R), Rintamod(R) and Alferon N Injection(R) which are in clinical stage. AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is based in Ocala, Florida.

Key Statistics

Overview:

Market Capitalization, $K 99,047
Shares Outstanding, K 47,849
Annual Sales, $ 160 K
Annual Net Income, $ -14,400 K
Last Quarter Sales, $ 20 K
Last Quarter Net Income, $ -5,880 K
60-Month Beta -0.84
% of Insider Shareholders 0.02%
% of Institutional Shareholders 15.12%
Float, K 47,839
% Float 99.98%

Growth:

1-Year Return -22.44%
3-Year Return -80.53%
5-Year Return -96.45%
5-Year Revenue Growth 23.08%
5-Year Earnings Growth 98.58%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/20/21
Earnings Per Share ttm -0.37
EPS Growth vs. Prev Qtr -50.00%
EPS Growth vs. Prev Year -9.09%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-12 on 08/29/16

AIM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -26.09%
Return-on-Assets % -24.77%
Profit Margin % -9,000.00
Net Margin % 0.17
Debt/Equity 0.03
Price/Sales 581.23
Price/Cash Flow N/A
Price/Book 1.54
Book Value/Share 1.37
Interest Coverage -20.49
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar